HeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.

HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...

Huawei Watch 5 Pro to launch on May 15, and leaks suggest it may feature an upgraded ECG sensor for better heart health ...

The study evaluated the mean difference in ECG intervals and amplitudes between HeartBeam's synthesized 12-lead ECG and simultaneously collected standard 12-lead ECG that are important in assessing ...

"This collaboration is a major step forward in delivering a more accessible and scalable solution for remote cardiac monitoring," said Robert Eno, Chief Executive Officer of HeartBeam. "AccurKardia ...

HeartBeam’s groundbreaking credit card-sized, cable-free 3D ECG device captures the heart’s electrical signals in 3 non-coplanar directions and then synthesizes these signals into a 12-lead ...